Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Data Collection & Analytics for Lunar Missions

Active

Grant

Response Deadline09/08/2026, 12:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Aeronautics And Space Administration, specifically the Space Operations Mission Directorate, is seeking a subcontractor to develop data collection frameworks and analytical models focused on health metrics. This initiative is designed to monitor and analyze astronaut health during lunar missions ranging from short-duration stays to month-long deployments. The opportunity was posted on August 11, 2026, with a response deadline of September 8, 2026. Classified under NAICS code 541711, the project emphasizes the creation of robust systems to ensure the well-being of crew members during extended lunar operations.

General Info

NASA seeks a subcontractor for astronaut health data frameworks and models for lunar missions.

Agency

National Aeronautics And Space Administration → Space Operations Mission DirectorateView Agency

NAICS

541711 - Research and Development in BiotechnologyView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of NNJ26ZSA003L.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Request for Information (RFI): What can we learn about human health and performance from astronauts living and working on a Moon Base?

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 11

subcontract

Response DeadlineSep 8

Submission deadline

Response Deadline

09/08/2026, 12:00:00 AM UTCin 25 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyNational Aeronautics And Space Administration → Space Operations Mission Directorate

ContactsNo contacts available

OfficeN/A

Organization / Agency

National Aeronautics And Space Administration → Space Operations Mission Directorate

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Design data collection frameworks and analytical models for health metrics during short-duration to month-long lunar missions.

Similar Contracts

Same NAICS industry code

Technical Data Acquisition & Reverse Engineering

Ok DLA Aviation At Oklahoma City

POSTED

DEADLINE

Pharmaceutical-Based Agent (PBA) Detection Systems

POSTED

DEADLINE

Dose Formulation and Compound Handling

National Institutes Of Health Olao

POSTED

DEADLINE

Integrated Phase I/II Clinical Trial DesignThe contract seeks the design and protocol development for an integrated Phase I/II clinical trial to evaluate ibogaine as a potential treatment for opioid use disorder, focusing on safety, optimal dosing, and therapeutic efficacy. The effort requires a comprehensive clinical framework that seamlessly merges the objectives of Phase I, which prioritizes dose escalation and toxicity profiling, with those of Phase II, which assesses preliminary effectiveness in reducing opioid dependence and withdrawal symptoms. The protocol must adhere to rigorous scientific and regulatory standards, incorporating appropriate patient selection criteria, monitoring procedures, endpoints, and risk mitigation strategies for a substance with significant pharmacological and safety considerations. The work is being pursued as a subcontract under the Advanced Research Projects Agency for Health, part of the Department of Health and Human Services, with a NAICS code indicating research and development in the life sciences. The solicitation was posted on August 5, 2026, and responses are due by October 15, 2026. The project is situated within a broader initiative to advance novel therapeutic interventions for the opioid crisis, requiring innovative trial design that balances exploratory research with clinical feasibility. There is no specified set-aside designation or location restriction for performance, indicating flexibility in execution while emphasizing scientific merit and regulatory alignment as key evaluation criteria.

Advanced Research Projects Agency For Health (arpa-H)

POSTED

DEADLINE

Phage-Based Formulation Development

W6QK Acc Ccdc Sttc

POSTED

DEADLINE

High-Throughput Yeast Two-Hybrid ScreeningA large-scale yeast two-hybrid screening project is being sought to identify protein-protein interactions between viral bait proteins and aphid prey libraries, encompassing all necessary laboratory procedures including yeast transformation and interaction assays. The effort is designed to enable high-throughput discovery of molecular connections critical to understanding viral infection dynamics in aphid hosts, with the goal of advancing agricultural pest and disease control strategies. This subcontract is designated as a Small Business Set Aside under NAICS code 541711, reserved exclusively for small business concerns, and is managed by the USDA Agricultural Research Service through its Albany Facility. The opportunity was posted on August 4, 2026, with a firm response deadline of August 28, 2026, and the performance location is specified as Ithaca, New York, with a zip code of 14853. The contract type and set-aside status emphasize support for small business participation in federally funded scientific research aimed at improving agricultural outcomes.

USDA Ars Afm Apd

POSTED

DEADLINE

Aphid cDNA Prey Library DevelopmentThe contract involves the development of a normalized cDNA library from aphid RNA supplied by the government, specifically for use in yeast two-hybrid prey systems. The work includes reverse transcription of the RNA into complementary DNA and subsequent cloning procedures to generate a high-quality, representative library that enables effective protein-protein interaction screening. The project is designed to support biological research efforts by providing a standardized, scalable prey library that enhances the reliability and depth of interaction data in functional genomics studies. This subcontract is designated as a Small Business Set Aside under the NAICS code 541711, indicating it is reserved for small businesses engaged in research and development in the life sciences. The work is to be performed in Ithaca, New York, with a response deadline of August 28, 2026, and was posted on August 4, 2026. The contracting entity is the USDA Agricultural Research Service, Agricultural Facilities Management and Application Personnel Division, and the project is intended to advance USDA’s mission in agricultural biotechnology and pest research through innovative molecular tools.

USDA Ars Afm Apd

POSTED

DEADLINE

Viral Bait Clone ConstructionThe contract involves the design and molecular cloning of viral protein bait constructs specifically for use in yeast two-hybrid systems, requiring comprehensive molecular biology expertise including codon optimization for host compatibility, precise plasmid insertion, and rigorous sequence validation to ensure accuracy and functionality. The work focuses on creating reliable protein baits that enable the study of virus-host protein interactions, which is critical for understanding pathogenic mechanisms and identifying potential therapeutic targets. All constructs must meet high standards of precision to support downstream functional assays in a controlled laboratory environment. The contract is designated as a Small Business Set Aside under NAICS code 541711 for scientific research and development, with performance to be carried out in Ithaca, New York, at the USDA ARS AFM APD facility. It was posted on August 4, 2026, and responses are due by August 28, 2026, with a clear emphasis on delivering technically robust and validated molecular reagents within the specified timeframe. The scope demands a high level of technical proficiency in molecular cloning, sequence analysis, and bioinformatics tools, with deliverables expected to support ongoing virology and host-pathogen interaction research funded by the U.S. Department of Agriculture.

USDA Ars Afm Apd

POSTED

DEADLINE

In Vitro ADMET AssaysThe contract titled In Vitro ADMET Assays calls for the performance of high-throughput in vitro screening focused on metabolic stability, hepatotoxicity, CYP450 enzyme interactions, and cellular permeability to support early-stage drug development. These assays are critical for evaluating the absorption, distribution, metabolism, excretion, and toxicity profiles of potential therapeutic candidates, enabling informed decisions before advancing compounds into costly clinical stages. The work will be conducted to meet the specific needs of the National Institutes of Health NIDA under the Department of Health and Human Services, with performance expected to occur in Bethesda. This is a subcontract opportunity under NAICS code 541711, which classifies it as research and development in the physical, engineering, and life sciences. The solicitation was posted on August 3, 2026, with a response deadline of August 18, 2026, at 7:00 PM Eastern Time. There is no set-aside classification specified, and no point of contact or detailed office address is provided in the data. Interested parties must submit their proposals before the deadline to be considered for award, with the expectation that the selected contractor will deliver reliable, scalable, and scientifically rigorous ADMET data to guide NIDA’s research initiatives in drug development.

National Institutes Of Health Nida

POSTED

DEADLINE

Genotoxicity and Carcinogenicity TestingThe contract seeks to perform in vitro and in vivo assays to assess the mutagenic and carcinogenic risks of drug candidates, ensuring compliance with regulatory safety standards for pharmaceutical development. The work is critical for identifying potential genetic toxicity and cancer-causing properties early in the drug evaluation process to support regulatory submissions and public health safeguards. The solicitation is issued as a subcontract under the National Institutes of Health NIDA, part of the Department of Health and Human Services, with performance expected to take place in Bethesda. It falls under the NAICS code 541711 for research and development in the physical, engineering, and life sciences. The proposal must be submitted by August 18, 2026, with the opportunity posted on August 3, 2026. No set-aside provisions are specified, and the contract is open to qualified subcontractors with the technical capacity to deliver high-quality genotoxicity and carcinogenicity testing services.

National Institutes Of Health Nida

POSTED

DEADLINE

Safety Pharmacology (CNS, Cardiovascular, Pulmonary)The contract requires comprehensive safety pharmacology studies to evaluate adverse effects on the central nervous system, cardiovascular system, and pulmonary function, ensuring alignment with ICH safety guidelines. The work will involve detailed pharmacodynamic assessments to identify and characterize potential risks to major organ systems during early drug development, with a focus on identifying safety signals that could impact clinical translation. This subcontract, issued by the National Institutes of Health’s NIDA under the Department of Health and Human Services, is set to be performed in Bethesda and has a response deadline of August 18, 2026. The effort is classified under NAICS code 541711, indicating it pertains to research and development in the life sciences, and is aimed at supporting regulatory-compliant preclinical safety evaluations essential for pharmaceutical advancement.

National Institutes Of Health Nida

POSTED

DEADLINE

Toxicity Testing (Acute, Subacute, Subchronic, Chronic)The contract requires the performance of comprehensive toxicity testing in both rodent and non-rodent models to assess organ toxicity and establish safety margins for submission to regulatory authorities as part of an Investigational New Drug application. The scope includes acute, subacute, subchronic, and chronic studies designed to evaluate the potential adverse effects of pharmaceutical compounds across a range of exposure durations and dosages. The work must meet rigorous scientific standards to support regulatory filings and ensure the safety profile of investigational drugs is adequately characterized prior to human trials. This subcontract is issued under the National Institutes of Health, National Institute on Drug Abuse, within the Department of Health and Human Services, with the performance location specified as Bethesda. The North American Industry Classification System code 541711 identifies the work as research and development in the life sciences. The solicitation was posted on August 3, 2026, with a mandatory response deadline of August 18, 2026, at 7:00 PM. No set-aside provisions are specified, and the contract opportunity is open to eligible contractors capable of executing preclinical toxicology studies to support IND submissions.

National Institutes Of Health Nida

POSTED

DEADLINE

More opportunities from National Aeronautics And Space Administration → Space Operations Mission Directorate

Same awarding agency

Risk Mitigation Technology DevelopmentThe National Aeronautics And Space Administration Space Operations Mission Directorate is seeking a subcontract for Risk Mitigation Technology Development. The primary objective of this effort is to identify and create technologies designed to protect human health during lunar missions, specifically focusing on the mitigation of radiation exposure, sleep disruption, and the psychological effects of isolation. This opportunity was posted on August 11, 2026, with a response deadline of September 8, 2026. The project falls under NAICS code 334510 and is managed through the NASA NSPIRES system.

Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

DEADLINE

Behavioral Health & Performance Monitoring SystemsThe Behavioral Health and Performance Monitoring Systems subcontract, issued by the National Aeronautics and Space Administration under the Space Operations Mission Directorate, focuses on the development of specialized tools and protocols. The primary objective is to monitor the mental health, cognitive performance, and team dynamics of astronauts participating in long-duration lunar missions. This opportunity was posted on August 11, 2026, with a response deadline of September 8, 2026. Classified under NAICS code 541690, the project seeks to ensure the psychological well-being and operational efficiency of crew members during extended spaceflight.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Lunar Human Physiology ResearchThe Lunar Human Physiology Research subcontract is issued by the National Aeronautics and Space Administration under the Space Operations Mission Directorate. The primary objective of this initiative is to investigate physiological adaptations occurring in partial gravity environments, specifically focusing on bone density loss, muscle atrophy, and cardiovascular changes to support future lunar missions. The opportunity was posted on August 11, 2026, with a response deadline of September 8, 2026. Classified under NAICS code 541715, this research effort seeks to provide critical data on how the human body responds to the unique gravitational conditions of the moon.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Request for Information (RFI): What can we learn about human health and performance from astronauts living and working on a Moon Base?

Solicitation # NNJ26ZSA003L

NASA's Space Operations Mission Directorate, through the Human Research Program, has issued Request for Information NNJ26ZSA003L to gather operationally relevant research ideas and identify challenges associated with human health and performance during a sustained presence on the Moon. This initiative supports the Artemis program's goal of establishing a Moon Base and understanding the physiological and psychological adaptations required for lunar gravity environments. The agency is specifically seeking input on health questions for short-duration missions of one week to one month, data collection needs during early base development, essential resources and technologies for risk mitigation, and the utility of uncrewed missions for collecting health data. This is a non-binding informational solicitation conducted under FAR 15.201(e) and is not a procurement for award; therefore, there is no contract value, formal evaluation criteria, or payment involved. Interested parties must submit their responses via the NSPIRES Notice of Intent module by the deadline of September 8, 2026. Submissions are restricted to plain text entries within the portal, with each response field limited to 4,000 characters. The primary point of contact for this effort is the NASA Human Research Program Chief Scientist.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Human Research Program Single-Source - by invitation only (FY 2026)

Solicitation # HRPSS26

POSTED

DEADLINE